1999
Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions.
Arpino C, Carrieri M, Valesini G, Pizzigallo E, Rovere P, Tirelli U, Conti F, Dialmi P, Barberio A, Rusconi N, Bosco O, Lazzarin A, Saracco A, Moro M, Vlahov D. Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. Annali Dell Istituto Superiore Di Sanità 1999, 35: 435-41. PMID: 10721210.Peer-Reviewed Original ResearchConceptsChronic fatigue syndromeDefinition of CFSFatigue syndromeIdiopathic chronic fatigueNumber of patientsSymptoms of individualsAcute onsetSore throatSymptomatic onsetIdiopathic fatigueChronic fatigueInfectious processEligibility criteriaPatientsSyndromeSymptomsOnsetSignsLymphadenopathyPharyngitisFatigueCasesCriteriaIndividuals
1995
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users
Dorrucci M, Rezza G, Vlahov D, Pezzotti P, Sinicco A, Nicolosi A, Lazzarin A, Galai N, Gafà S, Pristerà R. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. AIDS 1995, 9: 597-604. PMID: 7662199, DOI: 10.1097/00002030-199506000-00011.Peer-Reviewed Original ResearchConceptsAcute retroviral syndromeHIV infectionHIV seroconvertersRelative hazardDrug usersFirst positive HIV testYear of seroconversionPositive HIV testRate of CD4Kaplan-Meier estimatesCumulative AIDS incidenceAsymptomatic seroconvertersHIV seroconversionClinical characteristicsHIV testClinical progressionPrognostic valueProspective studyClinical centersSeroconvertersCell declineSeroconversionCell countSyndromeNatural historyAge, Gender, and Other Predictors of the Wasting Syndrome among HIV-1-Infected Injecting Drug Users
Sorkin J, Boiton P, Greenblatt J, Sithisarankul P, Vlahov D, Graham N. Age, Gender, and Other Predictors of the Wasting Syndrome among HIV-1-Infected Injecting Drug Users. Epidemiology 1995, 6: 172-177. PMID: 7742405, DOI: 10.1097/00001648-199503000-00015.Peer-Reviewed Original ResearchConceptsDrug usersDrug useFemale genderHuman immunodeficiency virus-1CD4 cell levelsCD4 T lymphocytesInjecting Drug UsersCase-control studyPresence of diarrheaImmunodeficiency virus-1Independent predictorsT lymphocytesSyndromeOlder ageWasting syndromeHIVWeight lossVirus 1AgeDiarrheaCrude predictorCohortPredictorsMore yearsLower percentage
1991
The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods
Vlahov D, Anthony J, Muñoz A, Margolick J, Nelson K, Celentano D, Solomon L, Polk B. The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods. Journal Of Drug Issues 1991, 21: 759-776. DOI: 10.1177/002204269102100406.Peer-Reviewed Original ResearchIntravenous drug usersHuman immunodeficiency virusDrug usersConfidential HIV testingHIV-1 infectionMonths of recruitmentALIVE studyHIV testingImmunodeficiency syndromeImmunodeficiency virusRisk factorsExtensive community outreachLongitudinal studyInfectionCommunity outreachBaltimore MarylandPercentSyndromeCohortRecruitmentProgressionMonths
1990
Occupationally Acquired Human Immunodeficiency Virus-1 Infection in Health Care Workers: A Review
Gershon R, Vlahov D. Occupationally Acquired Human Immunodeficiency Virus-1 Infection in Health Care Workers: A Review. 1990, 131-146. DOI: 10.1007/978-1-4684-5724-7_9.Peer-Reviewed Original ResearchHealth care workersCare workersHuman immunodeficiency virus-1 (HIV-1) infectionHIV-1-positive individualsHuman immunodeficiency virusVirus-1 infectionPublic health servicesHealth care systemImmunodeficiency syndromeImmunodeficiency virusPositive individualsHIV-1Health servicesInfected individualsType 1Care systemYear 20IndividualsSyndromeInfectionAIDS